Erasca, Inc. (NASDAQ:ERAS) Receives $4.83 Consensus Target Price from Brokerages
Erasca, Inc. (NASDAQ:ERAS – Get Free Report) has received an average rating of “Buy” from the six ratings firms that are currently covering the firm, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average twelve-month price objective among brokers that have issued ratings on the stock in […]
More Stories
Truist Financial Increases CVS Health (NYSE:CVS) Price Target to $82.00
CVS Health (NYSE:CVS – Free Report) had its price target increased by Truist Financial from $76.00 to $82.00 in a...
BMO Capital Markets Cuts Ascot Resources (TSE:AOT) Price Target to C$0.15
Ascot Resources (TSE:AOT – Free Report) had its price objective decreased by BMO Capital Markets from C$0.50 to C$0.15 in...
Foot Locker (NYSE:FL) Price Target Cut to $15.00 by Analysts at Evercore ISI
Foot Locker (NYSE:FL – Free Report) had its price objective lowered by Evercore ISI from $22.00 to $15.00 in a...
UBS Group Lowers Cushman & Wakefield (NYSE:CWK) Price Target to $9.00
Cushman & Wakefield (NYSE:CWK – Free Report) had its price target decreased by UBS Group from $14.00 to $9.00 in...
AppLovin (NASDAQ:APP) Price Target Cut to $450.00 by Analysts at UBS Group
AppLovin (NASDAQ:APP – Free Report) had its price objective reduced by UBS Group from $630.00 to $450.00 in a research...
Guardian Pharmacy Services (NYSE:GRDN) Price Target Raised to $25.00 at Truist Financial
Guardian Pharmacy Services (NYSE:GRDN – Free Report) had its price objective hoisted by Truist Financial from $24.00 to $25.00 in...